Citation 106400

AZUMA,Y: ONISHI,Y: SATO,Y: KIZAKI,H:. (1995). EFFECTS OF PROTEIN TYROSINE KINASE INHIBITORS WITH DIFFERENT MODES OF ACTION ON TOPOISOMERASE ACTIVITY AND DEATH OF IL-2-DEPENDENT CTLL-2-CELLS.. 118(2)

Citation Details

Title	EFFECTS OF PROTEIN TYROSINE KINASE INHIBITORS WITH DIFFERENT MODES OF ACTION ON TOPOISOMERASE ACTIVITY AND DEATH OF IL-2-DEPENDENT CTLL-2-CELLS.
Authors	AZUMA,Y: ONISHI,Y: SATO,Y: KIZAKI,H:
Year	1995
Volume	118
Issue	2

Summary

Year: 1995

Journal: Unknown

Organisms and Their Experiments (2)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	TOPOISOMERASE I INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAMPTOTHECIN	ACTIVE
2	TOPOISOMERASE II INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CAMPTOTHECIN	INACTIVE
3	DNA DISRUPTION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CAMPTOTHECIN	ACTIVE
4	TOPOISOMERASE I INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	ETOPOSIDE*	WEAK ACTIVITY
5	TOPOISOMERASE II INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ETOPOSIDE*	WEAK ACTIVITY
6	DNA DISRUPTION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	ETOPOSIDE*	ACTIVE
7	TOPOISOMERASE I INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	BIOCHANIN A	WEAK ACTIVITY
8	TOPOISOMERASE II INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BIOCHANIN A	ACTIVE
9	DNA DISRUPTION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	BIOCHANIN A	ACTIVE
10	TOPOISOMERASE I INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	WEAK ACTIVITY
11	TOPOISOMERASE II INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	WEAK ACTIVITY
12	DNA DISRUPTION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	TOPOISOMERASE I INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	HERBIMYCIN A	WEAK ACTIVITY
2	TOPOISOMERASE II INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	HERBIMYCIN A	WEAK ACTIVITY
3	DNA DISRUPTION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	HERBIMYCIN A	ACTIVE
4	TOPOISOMERASE I INDUCTION	PHARMACOLOGY OF COMPOUND - IN VITRO	STAUROSPORINE	WEAK ACTIVITY
5	TOPOISOMERASE II INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STAUROSPORINE	WEAK ACTIVITY
6	DNA DISRUPTION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	STAUROSPORINE	ACTIVE

Show SPARQL Queries (1)